Literature DB >> 8597837

Rhizomelic chondrodysplasia punctata: report of a case with review of the literature and correlation with other peroxisomal disorders.

D P Agamanolis1, R W Novak.   

Abstract

A 3-year-old girl with rhizomelic chondrodysplasia punctata (RCDP) had severe microcephaly but a normal gyral pattern, neuronal density, and cortical cytoarchitecture. The white matter was diffusely decreased in mass but normally myelinated. There was optic atrophy and cerebellar degeneration. Leukodystrophy in peroxisomal disorders is caused by elevated very long chain fatty acids. The absence of a fatty acid abnormality in RCDP explains the normal myelination. Cerebellar and retinal degeneration and possible stunted dendritogenesis may be due to plasmalogen deficiency, which is the most severe biochemical abnormality in RCDP.

Entities:  

Mesh:

Year:  1995        PMID: 8597837     DOI: 10.3109/15513819509026986

Source DB:  PubMed          Journal:  Pediatr Pathol Lab Med        ISSN: 1077-1042


  4 in total

1.  Peroxisomal multifunctional protein-2 deficiency causes motor deficits and glial lesions in the adult central nervous system.

Authors:  Steven Huyghe; Henning Schmalbruch; Leen Hulshagen; Paul Van Veldhoven; Myriam Baes; Dieter Hartmann
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

2.  The neurology of rhizomelic chondrodysplasia punctata.

Authors:  Annemieke M Bams-Mengerink; Johannes Htm Koelman; Hans Waterham; Peter G Barth; Bwee Tien Poll-The
Journal:  Orphanet J Rare Dis       Date:  2013-10-30       Impact factor: 4.123

Review 3.  Peroxisomes in brain development and function.

Authors:  Johannes Berger; Fabian Dorninger; Sonja Forss-Petter; Markus Kunze
Journal:  Biochim Biophys Acta       Date:  2015-12-11

4.  Peroxisomes in Different Skeletal Cell Types during Intramembranous and Endochondral Ossification and Their Regulation during Osteoblast Differentiation by Distinct Peroxisome Proliferator-Activated Receptors.

Authors:  Guofeng Qian; Wei Fan; Barbara Ahlemeyer; Srikanth Karnati; Eveline Baumgart-Vogt
Journal:  PLoS One       Date:  2015-12-02       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.